Abbott LaboratoriesABTNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+5.9%
5Y CAGR+6.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.9%/yr
vs +3.9%/yr prior
5Y CAGR
+6.5%/yr
Consistent
Acceleration
+2.0pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.59B | +14.6% |
| 2024 | $14.47B | +6.4% |
| 2023 | $13.60B | -2.6% |
| 2022 | $13.96B | -0.4% |
| 2021 | $14.01B | +16.0% |
| 2020 | $12.09B | -0.1% |
| 2019 | $12.10B | +1.0% |
| 2018 | $11.98B | +8.0% |
| 2017 | $11.09B | +38.8% |
| 2016 | $8.00B | - |